Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.
Stephen P. Schoenberger(La Jolla Institute for Immunology), Rienk Offringa(German Cancer Research Center), W. Martin Kast(University of Southern California), René E. M. Toes(Leiden University Medical Center), Liesbeth E. Jonges(Leiden University Medical Center), Rob J.D. Mooijaart(Dutch Blood Transfusion Society), Cornelis J.M. Melief(Leiden University), Franca C. Hartgers(Leiden University Medical Center)
PubMed
July 15, 1998
Cited by 66
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708